Información de la revista
Letter to the Editor
Open Access
Etanercept in the treatment of ankylosing spondylitis and nephrotic syndrome in the context of AA amyloidosis: A 48-month follow-up
Etanercept en el tratamiento de la espondilitis anquilosante y el síndrome nefrótico en el contexto de la amiloidosis aa: un seguimiento de 48 meses
Ana Domingosa,
Autor para correspondencia
ana_t_d@sapo.pt

Corresponding author.
, Joana Vidinhaa, Rui Osóriob, Teresa Jerónimoa, Célia Ribeiroc, Catarina Mendonçab, Mário Góisd, Pedro Leão Nevesa,e
a Division of Nephrology – Centro Hospitalar e Universitário do Algarve – Faro, Portugal
b Division of Internal Medicine – Centro Hospitalar e Universitário do Algarve – Faro, Portugal
c Division of Rheumatology – Centro Hospitalar e Universitário do Algarve – Faro, Portugal
d Laboratory of Renal Morphology, Hospital de Curry Cabral, Centro Hospitalar e Universitário de Lisboa Central, Portugal
e University of Algarve – Department of Biomedical Sciences and Medicine – Faro, Portugal

Artículo

This article is available in English

Etanercept in the treatment of ankylosing spondylitis and nephrotic syndrome in the context of AA amyloidosis: A 48-month follow-up

Ana Domingos, Joana Vidinha, Rui Osório, Teresa Jerónimo, Célia Ribeiro, Catarina Mendonça, Mário Góis, Pedro Leão Neves
10.1016/j.nefro.2020.04.019
Nefrologia. 2021;41:213-4
Idiomas
Nefrología
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?